Lipoprotein and apolipoprotein ratios in the VYTAL trial of ezetimibe/simvastatin compared with atorvastatin in type 2 diabetes

John R. Guyton, Ronald B. Goldberg, Theodore Mazzone, Ruth S. Weinstock, Adam Polis, Elizabeth Rosenberg, Andrew M. Tershakovec

Research output: Contribution to journalArticle

11 Scopus citations

Fingerprint Dive into the research topics of 'Lipoprotein and apolipoprotein ratios in the VYTAL trial of ezetimibe/simvastatin compared with atorvastatin in type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences